Top Markets
Coin of the day
Vetoquinol S.A. Vetoquinol S.A.

Vetoquinol S.A.

VETO
Rank in Stocks #9672
Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated... Vetoquinol S.A. is a prominent veterinary pharmaceutical enterprise dedicated to the innovation, development, and global commercialization of both medicinal and non-medicinal solutions for animal health. Its operations extend across Europe, the Americas, and the Asia Pacific regions. The company's diverse product portfolio addresses crucial therapeutic areas, including mobility, pain management, and inflammation; dermatological care and hygiene; anti-parasitic treatments; udder health; infectious disease control; reproductive solutions; behavior modification; internal medicine; and cardiovascular-renal support. These offerings cater to a wide spectrum of animals, encompassing livestock such as cattle, sheep, pigs, and poultry, alongside companion animals like dogs. Founded in 1933, Vetoquinol S.A. is headquartered in Lure, France, and functions as a subsidiary of Soparfin SCA.
Share Price
$83.27
Last synced: 2026-08-28
Market Cap
$967.96M
Change (1 day)
-0.85%
Change (1 year)
-5.99%
Country
FR
Trade Vetoquinol S.A. (VETO)

Category

P/B ratio for Vetoquinol S.A. (VETO)
P/B ratio as of 2026 TTM: 0
According to Vetoquinol S.A. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Vetoquinol S.A. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors